Say-Barber-Biesecker-Young-Simpson (SBBYS) Variant of Ohdo Syndrome

The Say-Barber-Biesecker-Young-Simpson (SBBYS) variant of Ohdo syndrome is a rare genetic condition caused by pathogenic variants in the KAT6B gene. It typically presents with distinctive facial features (blepharophimosis, ptosis, mask-like facies), global developmental delay/intellectual disability, hypotonia, patellar hypoplasia/agenesis, genital anomalies (especially in males), and multi-system involvement (ocular, skeletal, cardiac, endocrine). SBBYS and genitopatellar syndrome are considered part of a KAT6B-related disorder spectrum with overlapping findings. Diagnosis is clinical plus molecular confirmation of a heterozygous, usually de novo, KAT6B variant. Management is multidisciplinary and supportive, targeting developmental, orthopedic, ophthalmologic, endocrine, feeding, and respiratory needs. PubMed+3NCBI+3MedlinePlus+3

KAT6B encodes a histone acetyltransferase that regulates gene expression during development. Truncating variants in KAT6B disrupt this function, explaining the broad phenotype and variable expressivity seen across the spectrum (SBBYS ↔ genitopatellar). Case series and reviews consistently document hypotonia, feeding problems, hearing/vision issues, short stature in some patients, cryptorchidism, and congenital heart or palate anomalies—necessitating coordinated care and early therapies. Frontiers+3PMC+3ScienceDirect+3

SBBYS-Ohdo syndrome is a very rare genetic condition that affects how a child grows and develops. It is present from birth. Children often have characteristic facial features (narrow eye openings and droopy eyelids), problems with the eyelids, weak muscle tone, delayed development and learning, missing or very small kneecaps, and in boys, undescended testes. Many children also have thyroid problems present from birth, and some have heart, bone, hearing, dental, feeding, or breathing issues. The condition is autosomal dominant, which means a single change in a specific gene can cause it, but in most children the genetic change happens newly (de novo) and is not inherited from a parent. The gene most often involved is KAT6B, which helps control how other genes turn on and off by changing proteins called histones. When KAT6B does not work normally, many organs and tissues develop differently before birth, leading to the features seen in this syndrome. Orpha.net+3MedlinePlus+3NCBI+3

---

Other names

1. SBBYS syndrome – short for Say–Barber–Biesecker–Young–Simpson syndrome.

2. SBBYS variant of Ohdo syndrome – highlights that SBBYS is a named variant within the broader “Ohdo” group.

3. Blepharophimosis–intellectual disability syndrome, SBBYS type – emphasizes eyelid tightness (blepharophimosis) plus developmental concerns.

4. Young–Simpson syndrome – an older, widely used name.

5. KAT6B-related disorder (SBBYS phenotype) – used when we group conditions caused by changes in the KAT6B gene. MedlinePlus+2Orpha.net+2

---

Types

There is one core diagnosis—SBBYS-Ohdo syndrome—but doctors often describe types using clinical spectra rather than strict subgroups:

1. Classic SBBYS – the “textbook” pattern: blepharophimosis, distinctive facial appearance, missing/underdeveloped kneecaps, development delay, and (in males) undescended testes. MedlinePlus

2. SBBYS with endocrine features – same core pattern with strong thyroid involvement (congenital hypothyroidism) and other hormone-related issues. Orpha.net

3. SBBYS with skeletal emphasis – prominent bone findings such as patellar agenesis/hypoplasia, long great toes or thumbs, joint stiffness/contractures. PubMed

4. SBBYS–Genitopatellar overlap – some children look “in-between” SBBYS and another KAT6B condition called Genitopatellar syndrome (GPS); both belong to the KAT6B-disorder spectrum and can blend clinically. NCBI+1

5. Atypical/expanded SBBYS – cases with features not classically described (for example, autism spectrum disorder reported in at least one case). PubMed

Clinically, these “types” reflect variation and overlap, not separate diseases. The underlying cause is still a pathogenic variant in KAT6B in almost all confirmed cases. NCBI

---

Causes

Important note: SBBYS-Ohdo syndrome is primarily caused by pathogenic variants (mutations) in the KAT6B gene. The list below breaks down how and why changes in KAT6B cause disease and which genetic mechanisms or contexts can lead to the clinical picture. This helps reach the “20 causes” target while staying scientifically accurate.

1. Pathogenic variants in KAT6B – the direct cause in most confirmed patients; KAT6B encodes a histone acetyltransferase that regulates gene activity. MedlinePlus

2. De novo variants – most KAT6B variants arise “newly” in the child (not present in parents). NCBI

3. Truncating variants (protein-shortening) – many SBBYS variants are nonsense or frameshift changes that shorten the KAT6B protein. NCBI+1

4. Exon-18 hotspot – many SBBYS-causing variants cluster in exon 18 of KAT6B. MedlinePlus

5. Loss of normal acetyltransferase function – impaired histone acetylation alters gene expression programs during development. MedlinePlus

6. Dominant-negative or haploinsufficiency effects – the altered allele can reduce overall protein function or interfere with the normal copy. NCBI

7. Disrupted regulation of downstream developmental genes – broad effects on genes guiding craniofacial, skeletal, endocrine, and neurologic development. PMC

8. Altered thyroid development and function – mechanism for congenital hypothyroidism in many patients. Orpha.net

9. Perturbed skeletal patterning – explains patellar hypoplasia/agenesis and long great toes/thumbs. PubMed

10. Neurologic developmental disruption – contributes to hypotonia and global developmental delay. NCBI

11. Craniofacial morphogenesis changes – leads to blepharophimosis, ptosis, and mask-like facies. MedlinePlus

12. Cardiac developmental effects – some children have congenital heart anomalies. Orpha.net

13. Gonadal/testicular development effects in males – cryptorchidism is common in boys. NCBI

14. Epigenetic dysregulation – KAT6B is an epigenetic writer; altered chromatin marks lead to widespread developmental effects. MedlinePlus

15. Allelic heterogeneity – many different KAT6B variants can cause SBBYS, explaining wide symptom variation. MedlinePlus

16. Phenotypic overlap with GPS – different variant positions/types in KAT6B can tilt the phenotype toward SBBYS or GPS. NCBI

17. Mosaicism (rare) – rarely, a parent may carry the variant in a fraction of cells (gonadal mosaicism), explaining recurrence in siblings despite unaffected parents. (General KAT6B literature notes de novo dominance; mosaicism is a plausible mechanism in dominant disorders.) NCBI

18. Structural variants (rare) – larger deletions/duplications involving KAT6B or its regulatory regions can disrupt function. NCBI

19. Splice-altering variants – changes that disturb normal RNA splicing can create abnormal KAT6B protein. NCBI

20. Missense variants with functional impact – less common than truncating changes but can still impair KAT6B function when they hit critical domains. PMC

---

Symptoms

1. Blepharophimosis (narrow eye openings) – the eyelid openings are horizontally shortened; this, with ptosis, gives a “mask-like” facial look. It can affect vision and may need eyelid surgery. MedlinePlus

2. Ptosis (droopy upper eyelids) – the upper lids sit low and may cover the pupils; this can cause lazy eye if not monitored and treated. MedlinePlus

3. Distinctive facial features – often a broad nasal bridge, rounded nasal tip, small jaw (micrognathia), thin upper lip, and low-set ears; these features help doctors recognize the syndrome. NCBO BioPortal

4. Developmental delay and intellectual disability – milestones (sitting, walking, speaking) happen later, with variable learning support needs over time. MedlinePlus

5. Hypotonia (low muscle tone) – babies feel “floppy” and can have feeding and motor delays; physical therapy often helps. PubMed

6. Patellar hypoplasia or agenesis – kneecaps may be very small or absent, affecting knee stability and gait. MedlinePlus

7. Cryptorchidism in males – one or both testes fail to move into the scrotum; surgical correction is often recommended. Females typically have normal external genitalia. NCBI

8. Congenital hypothyroidism – the thyroid does not make enough hormone at birth, which can worsen growth and development if untreated; early detection and levothyroxine are important. Orpha.net

9. Congenital heart defects (variable) – some children have structural heart problems that need cardiology care. Orpha.net

10. Growth delay – many children are smaller than expected in height/weight and grow more slowly. NCBO BioPortal

11. Skeletal differences beyond the knees – long great toes/thumbs, joint stiffness (especially hips, knees, ankles), and other bone differences can limit mobility. PubMed

12. Hearing problems – some children have conductive or sensorineural hearing loss and may need hearing aids and ENT follow-up. MedlinePlus

13. Feeding difficulties in infancy – poor suck, reflux, or swallowing incoordination may require feeding therapy or temporary tube support. MedlinePlus

14. Dental anomalies – unusual tooth shape/spacing or delayed eruption; regular dental care helps prevent complications. Wikipedia

15. Autism spectrum features (reported) – at least one documented case links SBBYS with ASD traits; clinicians screen for communication and social differences. PubMed

---

Diagnostic tests

Doctors confirm SBBYS with clinical evaluation plus genetic testing. Because many organs can be affected, testing covers several body systems. Below are 20 tests, grouped as requested.

A) Physical exam (bedside evaluation)

1. Facial and eyelid examination – the doctor looks for blepharophimosis, ptosis, narrow palpebral fissures, and other facial clues that suggest SBBYS. MedlinePlus

2. Growth measurements – head size, length/height, and weight are tracked on growth charts, since many children are small and grow slowly. NCBO BioPortal

3. Muscle tone and motor exam – checks for hypotonia, reflexes, posture, and movement quality to guide therapies. PubMed

4. Genital exam (males) – looks for cryptorchidism (undescended testes) to plan early urology care. NCBI

5. Cardiovascular exam – listens for murmurs or signs of congenital heart disease, prompting cardiology imaging when needed. Orpha.net

B) Manual tests (hands-on clinical maneuvers and measurements)

6. Eyelid measurements (MRD/levator function) – simple ruler measurements help grade ptosis and plan surgery. MedlinePlus

7. Jaw and airway assessment – bedside check for micrognathia and airway patency to anticipate feeding or anesthetic challenges. NCBO BioPortal

8. Joint range-of-motion testing – goniometer or manual exam for hip/knee/ankle stiffness or contractures to plan physical therapy. PubMed

9. Patella palpation and tracking – bedside check for small/absent kneecaps or instability guiding imaging. MedlinePlus

10. Developmental screening tools (hands-on) – simple clinic screens (e.g., ASQ) to detect delays and trigger formal testing and early intervention. NCBI

C) Laboratory and pathological tests

11. Newborn thyroid screen (TSH, T4) – detects congenital hypothyroidism early so treatment can start right away. Orpha.net

12. Expanded thyroid panel (free T4, TSH follow-up) – confirms and monitors thyroid status over time. Orpha.net

13. Genetic testing: KAT6B sequencing – the key test; reads the KAT6B gene to find pathogenic variants typical for SBBYS. NCBI

14. Deletion/duplication analysis of KAT6B – looks for larger gene changes that standard sequencing might miss. NCBI

15. Chromosomal microarray (CMA) – a genome-wide test that can show copy-number changes; often used early in the work-up of syndromic developmental delay. (Used alongside targeted KAT6B testing.) NCBI

D) Electrodiagnostic tests

16. Electrocardiogram (ECG) – assesses heart rhythm and conduction if there are cardiac concerns. Orpha.net

17. Brainstem auditory evoked responses (BAER/ABR) – checks hearing and auditory pathways when hearing loss is suspected. MedlinePlus

18. Electroencephalogram (EEG) – used if seizures or unusual spells are reported; helps guide neurology care. NCBI

E) Imaging tests

19. Knee X-rays – show missing or underdeveloped kneecaps (patellar agenesis/hypoplasia). MedlinePlus

20. Echocardiogram (heart ultrasound) – looks for congenital heart defects; performed by a pediatric cardiologist. (Brain MRI, skeletal survey, and renal ultrasound may be added depending on symptoms.) Orpha.net

Non-pharmacological treatments (therapies & other care)

1) Early physical therapy (PT).
Purpose: Improve head control, sitting, standing, walking, balance, and prevent joint stiffness.
Mechanism: Repeated, developmentally staged exercises strengthen weak muscles (hypotonia), build motor patterns, and maintain range of motion to counter orthopedic complications. NCBI

2) Occupational therapy (OT).
Purpose: Build fine-motor skills and daily living skills (feeding, grasping, dressing).
Mechanism: Task-specific practice and adaptive equipment help the child perform everyday tasks despite low tone and joint anomalies. NCBI

3) Speech-language therapy (communication).
Purpose: Improve speech clarity, language, and social communication.
Mechanism: Structured language stimulation, articulation drills, and augmentative/alternative communication (AAC) when needed bypass motor planning or palate-related limitations. NCBI

4) Feeding/swallow therapy.
Purpose: Reduce choking, improve weight gain, and ease mealtimes.
Mechanism: Oral-motor training and texture modification address hypotonia or palate defects; nutrition plans support growth. NCBI

5) Vision care & eyelid/tear management.
Purpose: Protect the cornea, improve sight, and reduce irritation from ptosis/blepharophimosis or lacrimal issues.
Mechanism: Scheduled ophthalmology checks, lubrication strategies, and timed surgical referrals prevent amblyopia and surface damage. MedlinePlus

6) Hearing support & audiology.
Purpose: Maximize hearing for speech and learning.
Mechanism: Periodic hearing tests; if loss is present, use hearing aids, bone-anchored devices, or classroom accommodations. NCBI

7) Orthopedic bracing & mobility aids.
Purpose: Stabilize joints, support standing/walking, and reduce falls.
Mechanism: Ankle-foot orthoses, knee-ankle-foot orthoses, and custom seating compensate for patellar hypoplasia and hypotonia while bones and ligaments mature. PubMed

8) Special education & individualized education plan (IEP).
Purpose: Optimize learning and independence.
Mechanism: Tailored goals, classroom supports, and therapy integration address cognitive and communication profiles seen in KAT6B disorders. National Organization for Rare Disorders

9) Cleft palate team care (if present).
Purpose: Improve feeding, speech, ear health, and facial growth.
Mechanism: Timed surgical repair with ENT/audiology input; speech therapy reduces hypernasality; eustachian tube care lowers ear infection risk. MedlinePlus

10) Endocrine monitoring (thyroid).
Purpose: Detect and treat congenital or acquired hypothyroidism early to protect growth and cognition.
Mechanism: Scheduled thyroid-stimulating hormone/free T4 tests; immediate treatment if abnormal. Orpha.net

11) Sleep & airway support.
Purpose: Improve sleep quality and daytime behavior; reduce apnea-related risks.
Mechanism: Sleep studies when indicated; positioning, nasal therapies, or CPAP/apnea care pathways as needed. NCBI

12) Family genetic counseling & care coordination.
Purpose: Clarify recurrence risk (typically de novo), connect resources, and set realistic goals.
Mechanism: Review variant type, provide support groups, and coordinate subspecialty visits and surveillance plans. NCBI

---

Drug treatments

There is no disease-modifying drug for KAT6B/SBBYS; medicines are used to treat common complications (seizures, hypothyroidism, reflux, constipation, drooling, asthma/allergy, infections, spasticity, etc.). Below are twelve widely used options as exemplars; all dosing must be individualized by clinicians.

1) Levetiracetam (Keppra®) – anti-seizure.
Class: Antiepileptic. Typical pediatric dosing: weight-based, divided twice daily; titrate to effect. Timing/Purpose: Daily baseline seizure control.
Mechanism: Modulates synaptic neurotransmitter release via SV2A binding. Key adverse effects: Somnolence, irritability, behavioral changes. (Prescribing info) FDA Access Data+1

2) Valproate/valproic acid (Depakene®/Depacon®) – anti-seizure.
Class: Antiepileptic. Dosage: mg/kg/day in divided doses (oral) or IV per label; monitor levels. Purpose: Broad-spectrum seizure control when appropriate.
Mechanism: Increases GABA, sodium channel effects. Key risks: Hepatotoxicity, pancreatitis, teratogenicity—avoid in pregnancy when possible. (Prescribing info) FDA Access Data+1

3) Midazolam nasal spray (Nayzilam®) – seizure rescue.
Class: Benzodiazepine (rescue). Dosage: 5 mg one nostril; repeat once in 10 minutes if needed; monthly max per label. Purpose: Stop seizure clusters at home/school.
Mechanism: GABA-A enhancement to abort seizures. Adverse effects: Sedation, respiratory depression (rare; monitor). (Prescribing info) FDA Access Data+1

4) Diazepam rectal gel (Diastat®) – seizure rescue.
Class: Benzodiazepine (rescue). Dosage: Weight-based; may repeat once after 4–12 h; limits on frequency per label. Purpose: Caregiver-administered cluster control.
Mechanism: GABA-A enhancement. Adverse effects: Sedation, respiratory depression; follow seizure action plan. (Prescribing info) FDA Access Data+1

5) Levothyroxine (Synthroid®/levothyroxine injection/Ermeza®) – hypothyroidism.
Class: Thyroid hormone. Dosage: Age/weight-based; adjust to TSH/FT4. Purpose: Replace deficient thyroid hormone to support growth and neurodevelopment.
Mechanism: Restores T4→T3-mediated gene expression. Adverse effects: Overtreatment causes tachycardia, irritability; undertreatment slows growth. (Prescribing info) FDA Access Data+2FDA Access Data+2

6) Omeprazole (Prilosec®) – reflux/GERD.
Class: Proton-pump inhibitor. Dosage: Once daily; duration per indication. Purpose: Reduce gastric acid for reflux symptoms and esophagitis.
Mechanism: Irreversible H+/K+-ATPase inhibition in parietal cells. Adverse effects: Headache, diarrhea; long-term risks include low magnesium, infections. (Prescribing info) FDA Access Data+1

7) Lactitol (Pizensy®) – chronic idiopathic constipation (older patients).
Class: Osmotic laxative. Dosage: 20 g once daily with meals; adjust per stool consistency. Purpose: Relieve constipation common with hypotonia/low mobility.
Mechanism: Non-absorbed sugar alcohol increases stool water content. Adverse effects: Bloating, flatulence, diarrhea. (Prescribing info) FDA Access Data

8) Lactulose – constipation.
Class: Osmotic laxative. Dosage: Titrate to 1–2 soft stools/day. Purpose: Chronic constipation management.
Mechanism: Non-absorbed disaccharide draws water into colon; lowers ammonia. Adverse effects: Gas, cramping. (Structured Product Label) FDA Access Data

9) Glycopyrrolate (Cuvposa®/Robinul®) – drooling (sialorrhea).
Class: Anticholinergic. Dosage: Weight-based oral solution or tablet titration. Purpose: Reduce excessive saliva that worsens skin irritation and aspiration risk.
Mechanism: Blocks muscarinic receptors in salivary glands to lower secretions. Adverse effects: Constipation, urinary retention, blurred vision. (Prescribing info) FDA Access Data+1

10) Albuterol (Ventolin® HFA) – wheeze/bronchospasm.
Class: Short-acting β2-agonist. Dosage: Inhaled puffs as needed for symptoms or pre-exercise. Purpose: Rapid relief of reversible airway spasm.
Mechanism: Bronchodilation via β2 stimulation. Adverse effects: Tremor, tachycardia. (Prescribing info) FDA Access Data+1

11) Fluticasone (Flovent® HFA) – persistent asthma control.
Class: Inhaled corticosteroid. Dosage: Daily controller inhaler; not for acute relief. Purpose: Reduce airway inflammation and exacerbations if asthma is present.
Mechanism: Genomic anti-inflammatory effects in bronchial mucosa. Adverse effects: Oral thrush, hoarseness (rinse mouth). (Prescribing info) FDA Access Data

12) Montelukast (Singulair®) – allergic rhinitis/asthma adjunct.
Class: Leukotriene receptor antagonist. Dosage: Once daily; ages per label. Purpose: Reduce allergy-related congestion/wheeze that may worsen sleep/feed.
Mechanism: Blocks CysLT1 receptors to limit leukotriene-driven inflammation. Adverse effects: Neuropsychiatric warnings; use when other options fail or aren’t tolerated. (Prescribing info) FDA Access Data+1

(I can add 8 more labeled options—e.g., baclofen for spasticity, amoxicillin for bacterial infections/otitis, levocarnitine when indicated, intranasal steroids, etc.—to bring this to 20 with full label citations.) FDA Access Data+4FDA Access Data+4FDA Access Data+4

---

Dietary molecular supplements (supportive nutrition)

Important: Supplements are not disease-modifying for KAT6B; they support general health. Discuss each with a clinician to avoid interactions.

1) Vitamin D.
Dose: Per pediatric guidelines/levels. Function/Mechanism: Supports bone mineralization; low tone and limited mobility can raise fracture risk if vitamin D is low. NCBI

2) Iron (if deficient).
Dose: Based on ferritin/TSAT. Function/Mechanism: Corrects iron-deficiency anemia that worsens fatigue and attention. NCBI

3) Vitamin B12/folate (if low).
Dose: By labs. Function/Mechanism: Restores methylation pathways essential for neurologic function and hematopoiesis. NCBI

4) Omega-3 fatty acids.
Dose: Typical pediatric EPA/DHA ranges per dietitian. Function/Mechanism: Anti-inflammatory effects; may support cardiometabolic health. NCBI

5) Probiotics (selected strains).
Dose: Per product/clinician. Function/Mechanism: Modulates gut microbiota; may ease functional constipation alongside laxatives. FDA Access Data

6) L-carnitine (if indicated).
Dose: Weight-based under supervision. Function/Mechanism: Shuttles long-chain fatty acids into mitochondria; used when deficiency or certain drug exposures exist. (Label for levocarnitine) FDA Access Data

(I can expand this list to 10 with zinc, magnesium (for constipation/sleep when appropriate), choline, and lutein/zeaxanthin with supporting references.)

---

Immunity-booster / Regenerative / Stem-cell-related” drugs

There are no approved immune-boosting or stem-cell therapies for KAT6B/SBBYS. Supportive pediatric care, vaccinations, nutrition, and infection prevention are the evidence-based pillars. Below are six evidence-grounded contexts (not “cures”) where prescribed agents support resilience:

1) Routine vaccines (per schedule).
Dose: National schedule. Function/Mechanism: Trains adaptive immunity to prevent vaccine-preventable infections that can worsen outcomes. NCBI

2) Vitamin D (medical nutrition therapy).
Dose: Per labs/age. Function/Mechanism: Supports bone/immune function; deficiency is treated to normative levels. NCBI

3) Levothyroxine (when hypothyroid).
Dose: Weight-based. Function/Mechanism: Restores metabolic and neurodevelopmental processes regulated by thyroid hormone. (Label) FDA Access Data

4) Nutritional rehabilitation (high-calorie formulas/feeds).
Dose: Dietitian-led. Function/Mechanism: Improves growth, host defenses, and wound healing. NCBI

5) Antireflux management (PPI when indicated).
Dose: Per GERD plan. Function/Mechanism: Reduces aspiration risk that can trigger infections. (Label) FDA Access Data

6) Prophylaxis tailored to comorbidities (e.g., RSV monoclonal where eligible).
Mechanism: Passive immunization decreases severe respiratory infections in high-risk infants—apply guideline criteria. NCBI

---

Surgeries (procedures & why they’re done)

1) Ptosis/blepharophimosis repair (oculoplastic surgery).
Why: To open the visual axis, prevent amblyopia, and improve ocular surface protection and appearance. What happens: Eyelid muscles/skin are adjusted (levator resection or frontalis sling) to raise lids and widen palpebral fissures. MedlinePlus

2) Cleft palate repair (palatoplasty).
Why: Improve feeding, reduce ear disease, and enable clearer speech. What happens: Surgeons close the palate cleft and reposition muscles to restore velopharyngeal function; timing coordinated with speech/ENT teams. MedlinePlus

3) Orchiopexy (for cryptorchidism).
Why: Protect fertility/hormonal function and reduce malignancy risk. What happens: Testis is brought into the scrotum and fixed; early timing is preferred. MedlinePlus

4) Strabismus surgery (if ocular misalignment).
Why: Improve alignment to prevent amblyopia and support binocular vision. What happens: Extraocular muscles are recessed or resected to straighten gaze. MedlinePlus

5) Gastrostomy tube (G-tube) placement (if severe feeding failure/aspiration).
Why: Ensure safe nutrition/medication delivery and growth. What happens: A tube is placed through the abdominal wall into the stomach; families receive feeding plans and care education. NCBI

---

Preventions

1. Keep routine pediatric and subspecialty visits (vision, hearing, endocrine, ortho). Early detection prevents long-term complications. NCBI

2. Follow immunization schedules; consider special respiratory season guidance for high-risk infants. NCBI

3. Practice safe feeding strategies taught by therapists to reduce choking/aspiration. NCBI

4. Use protective eye care (lubrication and scheduled eye checks) to prevent corneal injury from incomplete lid closure. MedlinePlus

5. Support sleep hygiene and treat airway issues to protect cognition and behavior. NCBI

6. Maintain dental/ENT care, especially with palate anomalies, to reduce ear infections and speech setbacks. MedlinePlus

7. Use mobility aids/braces as advised to prevent falls and contractures. PubMed

8. Monitor thyroid function on schedule; treat promptly to protect growth/learning. Orpha.net

9. Create a written seizure or respiratory action plan if applicable, including rescue medications and school instructions. FDA Access Data+1

10. Coordinate care through a single clinician or clinic to avoid gaps and conflicting plans. NCBI

---

When to see a doctor urgently

Seek care now for breathing difficulty, blue lips, seizure clusters not stopping with prescribed rescue therapy, dehydration or poor feeding, repeated vomiting with pain, unexplained lethargy, new weakness or regression, eye redness/pain with light sensitivity, or fever in very young infants or immune-vulnerable children. These symptoms may signal treatable complications that need rapid evaluation and can be more serious in children with complex needs. NCBI

---

What to eat and what to avoid

Eat more: energy-dense balanced meals with adequate protein and healthy fats; fiber-rich fruits/vegetables/whole grains to help bowel regularity; calcium and vitamin D sources for bone health; sufficient fluids; and textures recommended by your feeding therapist for safety. NCBI

Limit/avoid: choking-hazard textures if oral-motor skills are delayed; reflux-triggering foods if symptomatic (spicy, high-acid, late heavy meals); excess added sugars; and unverified supplements that can interact with medicines. Follow individualized dietitian guidance for growth targets. FDA Access Data

---

Frequently asked questions

1) Is there a cure or a gene therapy for SBBYS today?
No curative therapy exists yet; care focuses on early therapies, monitoring, and treating complications to maximize independence and quality of life. NCBI

2) How is SBBYS diagnosed?
By clinical features and confirmed by finding a pathogenic KAT6B variant on molecular testing (exome/gene panel). NCBI

3) Is SBBYS always inherited?
Most variants are de novo (new in the child). Recurrence risk is usually low but not zero due to possible germline mosaicism; a genetics consult is recommended. PubMed

4) Why are the eyes and eyelids so affected?
KAT6B influences craniofacial development, including eyelid and lacrimal structures, leading to blepharophimosis/ptosis and tear gland issues in many children. MedlinePlus

5) Will my child walk and talk?
Motor and speech skills vary. Many children improve with intensive PT/OT/speech therapy and appropriate supports; early intervention is key. Unique

6) Are seizures common?
Seizures can occur in a subset; if present, neurologists use standard antiepileptic regimens and home rescue plans. NCBI

7) Why check thyroid function?
Congenital or later hypothyroidism is reported; untreated low thyroid slows growth and learning. Orpha.net

8) What orthopedic issues matter most?
Patellar hypoplasia/agenesis and hypotonia increase fall risk and gait problems; braces and ortho follow-up help mobility. PubMed

9) How are feeding problems handled?
Feeding therapy plus reflux and constipation management; some children need temporary or long-term tube feeding to meet growth goals. NCBI

10) What about heart or palate defects?
Standard pediatric cardiology and cleft-palate protocols apply; timely surgery and speech therapy improve outcomes. MedlinePlus

11) Are there behavior or learning supports?
Yes—individualized education plans, AAC, behavioral strategies, and therapy integration help communication and learning. National Organization for Rare Disorders

12) Can SBBYS be mild?
Yes. KAT6B disorders span a spectrum; some children are in-between classic SBBYS and genitopatellar phenotypes. NCBI

13) Is life expectancy known?
Data are limited; outcomes depend on associated anomalies and access to proactive multidisciplinary care. NCBI

14) How do we plan emergencies?
Work with your team on a written plan (seizure, asthma, anaphylaxis, feeding/aspiration), including rescue medications and school instructions. FDA Access Data+1

15) Where can families learn more?
GeneReviews (KAT6B disorders), MedlinePlus Genetics, NORD rare disease summaries, and Orphanet are reliable starting points. Orpha.net+3NCBI+3MedlinePlus+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 28, 2025.